5 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
Follow Alcohol Drinking: new trials by email Literature Review of Alcohol Drinking trials Research Report on Alcohol Drinking
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Does Oxytocin Alter Tolerance to or Motivation for Alcohol Intranasal oxytocin, Intranasal placebo - Alcohol Use Disorder | Phase 2 | Terminated | Indiana University | 6 | 2022-01-16 | 2025-03-04 |
| A Novel Compound for Alcoholism Treatment: A Translational Strategy - Part II PF-05190457, Placebo - Alcoholism | Phase 2 | Terminated | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 42 | 2016-06-15 | 2022-03-16 |
| Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults Ondansetron, Placebo, BASICS Plus - Alcohol Abuse, Alcoholism | Phase 2 | Terminated | University of Maryland, Baltimore | 74 | 2015-09-01 | 2023-05-26 |
| Topiramate's Effects on Heavy Drinking Topiramate, Placebo - Alcohol Drinking | Phase 2 | Terminated | University of Pennsylvania | 1 | 2015-05-01 | 2018-09-21 |
| Role of Proinflammatory Signaling in Alcohol Craving Pioglitazone, Placebo - Alcohol Dependence, Alcohol Drinking | Phase 2 | Terminated | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | 16 | 2012-05-01 | 2017-03-09 |
Alcoholism (4) · Alcohol-Related Disorders (1) · Binge Drinking (1) · Tobacco Use Disorder (1)
Behavior (5) · Drinking Behavior (5) · Chemically-Induced Disorders (4) · Mental Disorders (4) · Substance-Related Disorders (4) · Alcohol-Related Disorders (3)
Sugars (2) · Ondansetron (1) · PF-5190457 (1) · Pioglitazone (1) · Topiramate (1)
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (2) · Indiana University (1) · University of Maryland, Baltimore (1) · University of Pennsylvania (1)
United States (5)
Bankole Johnson, DSc,MD,PhD (1) · Henry R Kranzler, MD (1) · Lorenzo Leggio, M.D., PhD (1) · Martin H Plawecki, MD, PhD (1) · Nancy Diazgranados, M.D. (1) · Reagan R Wetherill, PhD (1)
PMID 32445052, PMID 39704175, PMID 41474196
R01AA010522 (1)